Treatment of an infantile acne with oral isotretinoin

Eur J Dermatol. 2004 Jan-Feb;14(1):71-2.

Abstract

We report the case of a little girl who presented with a nodulocystic acne which had its onset at the age of 20 months. She had no clinical or biological features of endocrinopathy. The lesions did not respond to conventional antibiotics so she was started on oral isotretinoin. A seven-month treatment period was necessary to achieve remission. The onset of infantile acne is usually around 6 to 16 months and there is a male predominance. The onset is later in females. Oral erythromycin is the first line treatment when topical therapies are inefficacious. Some cystic lesions do not respond to oral antibiotics. In these cases, oral isotretinoin may be effective and the treatment is similar to that of an adult. Clinical and biological tolerance is good with no growth retardation. Lesions may relapse after the withdrawal of isotretinoin but they are less important and easily controlled with topical treatments. Isotretinoin can be used for nodulocystic acne to reduce the risk of scarring.

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris / diagnosis*
  • Acne Vulgaris / drug therapy*
  • Administration, Oral
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Isotretinoin / therapeutic use*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Isotretinoin